Open Access iconOpen Access

ARTICLE

Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab

RYUL KIM1,#, JOO KYUNG PARK2,#, MINSUK KWON3, MINAE AN4, JUNG YONG HONG1, JOON OH PARK1, SUNG HEE LIM1,*, SEUNG TAE KIM1,*

1 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 Department of Hematology-Oncology, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, Korea
4 Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University School of Medicine, Seoul, Korea

* Corresponding Authors: SUNG HEE LIM. Email: email; SEUNG TAE KIM. Email: email
# These authors contributed equally

TSP_OR_49054.pdf

  • 717

    View

  • 123

    Download

  • 0

    Like

Share Link